{
  "api": "2.0",
  "content": {
    "html": "<h1 id='0' style='font-size:22px'>A형간염</h1>\n<h1 id='1' style='font-size:20px'>요약문</h1>\n<br><figure id='2'><img style='font-size:16px' alt=\"건강담기 수정 문의\" data-coord=\"top-left:(931,0); bottom-right:(1216,34)\" /></figure>\n<p id='3' data-category='paragraph' style='font-size:14px'>■ 등록일자 : 2020-03-09 ■ 업데이트: 2025-02-20 ■ 조회 : 19027 정보신청 126</p>\n<h1 id='4' style='font-size:22px'>개요</h1>\n<br><p id='5' data-category='paragraph' style='font-size:18px'>A형간염 바이러스 감염에 의한 급성 간염 질환으로, 제2급 법정감염병에 해당합니다.</p>\n<h1 id='6' style='font-size:20px'>개요-신고 대상 및 방법</h1>\n<p id='7' data-category='paragraph' style='font-size:18px'>신고범위 : 환자, 의사환자, 병원체보유자</p>\n<p id='8' data-category='paragraph' style='font-size:18px'>: 신고를 위한 진단기준</p>\n<p id='9' data-category='list' style='font-size:18px'>, 환자 : A형 간염에 부합되는 임상증상을 나타내면서, 확인 진단을 위한 검사 기준에 따라 감염병 병원체 감염이 확인된 사람</p>\n<p id='10' data-category='list' style='font-size:18px'>· 의사환자 : 임상증상 및 역학적 연관성\"을 감안하여 A형간염이 의심되나 진단을 위한 검사기준에 부합하는 검사결과가 없는 사람<br>+ 역학적 연관성 : 환자의 증상발생 전 15~50일 동안 감염력이 있는\" A형간염 환자와 일상접촉 성접촉 경력이 있는 경우<br>+*환자의 증상 발생 2주전 - 증상발생 1주 후<br>· 병원체보유자 : 임상증상은 없으나 진단을 위한 검사기준에 따라 감염병병원제 감염이 확인된 사람</p>\n<p id='11' data-category='paragraph' style='font-size:16px'>· 진단을 위한 검사기준</p>\n<p id='12' data-category='list' style='font-size:18px'>' 검체(혈액)에서 특이 IgM 항체 검출<br>· 검체(혈액, 대변, 직장도말)에서 특이 유전자 검출</p>\n<p id='13' data-category='paragraph' style='font-size:18px'>신고시기 : 24시간 이내 신고</p>\n<p id='14' data-category='paragraph' style='font-size:18px'>신고 방법 : 신고세를 작성하여 관할 보건소로 팩스 또는 웹[바로가기]의 방법으로 신고</p>\n<h1 id='15' style='font-size:20px'>개요-원인 및 감염경로</h1>\n<p id='16' data-category='paragraph' style='font-size:16px'>1. 전파경로</p>\n<br><p id='17' data-category='paragraph' style='font-size:18px'>대부분의 경우 A형 간염 바이러스에 오염된 물이나 음식 등을 섭취하면서 경구를 통해 감염되나, 주사기를 통한 감염(습관성 약물 중독자), 혈액제제를 통한 감염,<br>성접촉을 통한 감염 등 비경 구 적으로도 전화될 수 있습니다. 주로 경구를 통해 감염되므로 환자를 통해 가족 또는 친척에게 전파되거나 안구말도가 높은 군대,<br>보육원 등 집단시설에서 집단 발생할 수 있습니다.</p>\n<p id='18' data-category='paragraph' style='font-size:18px'>2. 전명기간</p>\n<br><p id='19' data-category='paragraph' style='font-size:18px'>증상 발현 2주 젠부터 황달이 생긴 후 1주일까지이며, 증상이 발현하기 1~2주 전이 가장 감염력이 높은 시기입니다.</p>\n<h1 id='20' style='font-size:20px'>역학 및 통계</h1>\n<br><p id='21' data-category='paragraph' style='font-size:18px'>대부분 공중위생 상태가 나쁜 경우 잘 생기므로 위생 수준이 멀막했던 1960~70년대에는 소아기 감염으로 자연면역이 형성되어 성인 발생 반도가 매우<br>낮았습니다. 그러나 최근에는 위생수준 향상으로 소아기 감염이 거의 없어지게 되고 그보다는 성인 연령증(20~40대)에서의 발생 반도가 급격하게 증가하고<br>있습니다. 즉, 위생 상태 불량으로 인한 후진국형 유행 양상에서 선진국형 양상으로 변모된 것입니다. 질병관리본부에서는 200 1년부터 2009년도까지는<br>A형간염을 표본감시 대상 감염병으로서 유행을 모니터링하였으며, 2010년 제정된 '감염병의 예방 및 관리에 관한 법률' 에서 A형간염을 제2급 감염병으로<br>지정함에 따라 이 질환을 전수 감시하기 시작하였습니다.</p>\n<br><p id='22' data-category='paragraph' style='font-size:18px'>국내에서는 20~40대가 전체 환자의 80% 이상을 차지하며, 2011년 5,521명 발생 이후 매년 1,000여 명 수준으로 신고되었습니다. 그러다가 2016~2017년<br>4,500명 내외로 급증한 이후 2018년 2,437명으로 감소했다가 2019년 대규모 유행으로 17,000명 이상의 확진자가 발생하였습니다.</p>\n<p id='23' data-category='paragraph' style='font-size:14px'>. 표 시험 간염의 국내현황></p>\n<br><table id='24' style='font-size:14px'><tr><td>연도</td><td>2010년</td><td>2011년</td><td>2012년</td><td>2013년</td><td>2014년</td><td>2015년</td><td>2016년</td><td>2017 년</td><td>2018년</td><td>20:18 년</td></tr><tr><td>신고 건수 (전수림시체계)</td><td></td><td>5,521 견</td><td>1,197건</td><td>867 건</td><td>1,307,건</td><td>1,804 간</td><td>4,679 건</td><td>4,419 건</td><td>2,437 건</td><td>17,598 권</td></tr></table>\n<p id='25' data-category='list' style='font-size:14px'>·A형 간염 : 2000년 지정감염병/표본검사) - 2010년(제1군 감염병/전수강시) - 2020년(제2급 김명병/전수감씨)<br>- 출처 : 질병관리본부 (2020), 감염 법포될 http://www kdca.go krtmpt/bla/npp/itt/imple/smplefstScatskstatem. do?lcdCd=N800086/cdg/pCd=02</p>\n<h1 id='26' style='font-size:22px'>증상</h1>\n<p id='27' data-category='paragraph' style='font-size:18px'>1. 장복기</p>\n<br><p id='28' data-category='paragraph' style='font-size:18px'>감염 후 15~50일로 평균 28~30일의 잠복기 후 임상증상이 나타납니다.</p>\n<p id='29' data-category='paragraph' style='font-size:18px'>2. 임상증상</p>\n<br><p id='30' data-category='paragraph' style='font-size:18px'>발열, 식욕감퇴, 구역, 구토, 쇠약감, 복통, 설사 등 다른 바이러스 간염과 유사합니다. 일주일 이내에 특징적인 황달 증상이 발생하는데, 각막 및 피부 황달, 콜라색<br>소변, 전신 가려움증 등에 이에 속합니다. 소아의 경우 6세 미만에서 대부분 무증상(약 70%)이며 약 10%에서만 황달 증상이 발생하나, 연령이 높아질수록<br>증상에 심한 경우가 않습니다. 치명적인 전격성 간염으로 발전하는 경우는 0.1~0.3%로 알려져 있으나, 50세 이상에서는 1.8%로 높아집니다.</p>\n<br><p id='31' data-category='paragraph' style='font-size:18px'>수주~수개월 후 회복되며 만성 간염은 없으나, 감염 환자의 약 15%는 A형간염이 1년까지 지속 또는 개발할 수 있다고 알려져 있습니다.</p>\n<br><p id='32' data-category='paragraph' style='font-size:20px'>진단 및 검사</p>\n<p id='33' data-category='paragraph' style='font-size:14px'>항A형 간염 바이러스 면역글로불린 M(IgM anti-HAV) 항체 검사 혹은 역전사중합효소연쇄반응법(RT-PCR) 등으로 A형간염 바이러스의 표적 유전자를 확인하는<br>방법을 통해 확진합니다. 면역글로불린 M 항체는 증상이 나타나기 5-10일 전부터 나타나 감염 후 6개월까지도 지속될 수 있습니다. 면역글로불린 G(IgG anti-<br>HAV) 항체는 간염의 회복기에서 양성으로 나타나며, 평생 지속됩니다.</p>\n<figure id='34'><img alt=\"\" data-coord=\"top-left:(1416,190); bottom-right:(1951,481)\" /></figure>\n<p id='35' data-category='paragraph' style='font-size:14px'>[경과]</p>\n<br><p id='36' data-category='paragraph' style='font-size:14px'>황달이 생기기 전 혈청 간 효소가 증가하며, 알라닌아미노전이효소(ALT, GPT) 수치가 아스파라진산 아미노전이효소(AST, GOT) 수치보다 훨씬 증가하게 됩니다.<br>황달을 진단하는 혈청 빌리루빈 수치는 대개 10 이상 증가하며, 기타 염증 인자 수치도 증가하게 됩니다.</p>\n<p id='37' data-category='paragraph' style='font-size:20px'>예방 및 예방접종</p>\n<p id='38' data-category='paragraph' style='font-size:14px'>• 공중 보건위생 : 손 씻기, 상하수도 정비, 식수원 오염방지, 식품 및 식품 취급자 위생관리 등이 중요합니다.</p>\n<p id='39' data-category='list' style='font-size:14px'>• A형간염 백신 접종<br>1회 접종 후 6~12개월이 지나면 1회 더 접종하며, 면역은 20년 이상 지속됩니다. 다음의 상황에서 우선적으로 접종합니다.<br>- 12~23개월의 모든 소아<br>- A형간염에 대한 면역력이 없는 고위험군* 소아청소년이나 성인<br>* A형간염 고위험군<br>- 유행지역 여행자 및 장기 체류자<br>- 남성 동성애자<br>- 불법 약물 남용자<br>- 직업적으로 A형 간염에 노출될 위험이 있는 자<br>- 만성 간질환 환자<br>- 혈액응고 질환자<br>- A형간염 환자와 접촉하는 자</p>\n<p id='40' data-category='paragraph' style='font-size:20px'>치료</p>\n<p id='41' data-category='paragraph' style='font-size:14px'>아직까지 A형 간염 바이러스를 치료하는 약은 개발되지 않았습니다. 일반적으로 증상을 완화시키기 위한 대증요법이 주된 치료이며, 고단백 식이요법과 간에<br>휴식을 주는 것이 치료에 도움이 됩니다. 심한 증상을 동반하는 경우에는 입원 치료를 하여 증상을 완화시켜 주기도 합니다.</p>\n<p id='42' data-category='paragraph' style='font-size:20px'>합병증</p>\n<p id='43' data-category='paragraph' style='font-size:14px'>A형 간염의 합병증으로 길랭-바레 증후군, 급성 신부전, 담낭염, 췌장염, 혈관염, 관절염 등이 생길 수 있습니다. 소수에서 재발성 간염, 자가 면역성 간염, 담즙<br>정체성 간염 등의 비전형적인 임상 증상이 나타날 수 있습니다. 전격성 간염은 가장 중증의 합병증으로 치명률이 80%에 이른다고 알려져 있습니다.</p>\n<p id='44' data-category='paragraph' style='font-size:20px'>대상별 맞춤 정보</p>\n<p id='45' data-category='paragraph' style='font-size:14px'>1. 환자 발견</p>\n<br><p id='46' data-category='paragraph' style='font-size:14px'>다른 바이러스성 간염에서와 같이 A형 간염도 발열, 식욕부진, 구역, 전신 쇠약감 등의 비특이적인 증상으로 시작하는데, 일반적인 치료에도 불구하고 증상<br>호전이 없고, 진행하여 황달 등의 간염의 특이 증상들이 발생할 때는 의사의 진료를 받아 보는 것이 좋습니다.</p>\n<p id='47' data-category='paragraph' style='font-size:14px'>2. 환자 관리</p>\n<br><p id='48' data-category='paragraph' style='font-size:14px'>입원 치료가 원칙이며, 증상 및 감염력이 소실될 때까지 실시합니다. A형 간염은 대부분 환자의 대변으로 배설되어 전파되므로 장내 배설물을 격리하고, 발병 후<br>2주간 또는 황달 발생 1주간은 전염력이 높으므로 이 기간은 특별히 주의해서 손 씻기 등 개인위생을 철저히 하는 것이 좋습니다.</p>\n<p id='49' data-category='paragraph' style='font-size:14px'>3. 접촉자 관리</p>\n<br><p id='50' data-category='paragraph' style='font-size:14px'>환자 접촉자는 노출 후 50일간 발병 여부를 감시합니다. 또한 노출 후 2주 이내에 예방접종 또는 면역글로불린 투여를 통해 예방할 수 있는데, 노출 후 예방접종은<br>빨리 접종할수록 효과가 높으므로 되도록 빠른 시간 내에 접종하도록 합니다. 12개월 미만의 영아이거나 백신 금기사항이 있는 경우에 해당하는 사람은<br>면역글로불린을 투여하며, 그 외 면역저하자나 만성간질환자, 혹은 고령자의 경우에는 담당 의료진이 위험평가 후 필요성에 따라 투여를 고려합니다.</p>\n<p id='51' data-category='paragraph' style='font-size:20px'>자주하는 질문</p>\n<p id='52' data-category='paragraph' style='font-size:16px'>Q. A형간염 백신을 꼭 접종해야 하나요?</p>\n<p id='53' data-category='paragraph' style='font-size:14px'>A.</p>\n<p id='54' data-category='paragraph' style='font-size:16px'>Q. A형간염 백신의 2차 접종을 실수로 3개월 만에 했습니다. 이후 접종을 어떻게 해야 할까요?</p>\n<br><p id='55' data-category='paragraph' style='font-size:14px'>A형간염 고위험군의 경우 접종을 해야 합니다.A형간염에 대한 면역력이 없는 성인 중 A형간염의 유행지역(미국, 캐나다, 서유럽, 북유럽, 일본, 뉴질랜드,<br>호주 이외의 국가)으로의 여행자나 장기 체류자, 남자 동성애자, 불법약물 남용자, 직업적으로 노출될 위험이 있는 자(실험실 종사자, 의료인, 군인, 요식업<br>종사자 등), 만성 간 질환자, 혈액응고 질환자, A형간염 환자와 접촉하는 자, A형간염에 대한 면역을 얻기 원하는 자에게 접종을 합니다. 이들 중 만 40세<br>미만에서는 항체검사 없이 접종하고, 40세 이상에서는 항체검사를 실시하고 항체가 없는 경우에만 접종합니다.</p>\n<p id='56' data-category='paragraph' style='font-size:14px'>A.</p>\n<p id='57' data-category='paragraph' style='font-size:16px'>1차와 2차와의 최소 접종간격이 6개월이므로 확실한 면역을 얻기 위해서는 잘못 접종 받은 날로부터 최소 6개월 후 재접종 해야 합니다.A형간염 백신의 2차<br>접종시기는 백신의 종류에 따라 차이가 있으나 모두 1차 접종 6개월 이후로 6~12개월에 실시합니다. 이것의 의미는 1차와 2차와의 최소 접종간격이<br>6개월이라는 것입니다. 따라서 확실한 면역을 얻기 위한 올바른 재접종 시기는 2차 접종의 6~12개월 후입니다.</p>\n<p id='58' data-category='paragraph' style='font-size:20px'>Q. A형간염 백신의 접종 전이나 후에 항체검사를 해야 하나요?</p>\n<br><p id='59' data-category='paragraph' style='font-size:16px'>A.</p>\n<p id='60' data-category='paragraph' style='font-size:16px'>A형간염의 방어항체 양성률은 2차 접종 후에는 거의 100%에 달하므로 접종 후의 항체검사는 필요하지 않습니다.백신 접종 전의 항체검사의 실시여부는<br>백신 가격과 검사 비용 간의 경제적 요인 및 인구의 항체 보유율에 의해 결정됩니다. 만약 백신 접종력이나 A형간염의 이환력이 없어 백신을 접종하기로<br>결정하였다면 만 40세 미만에서는 검사 없이 백신을 접종하고, 40세 이상이라면 백신 투여 전에 검사를 시행하여 항체가 없는 경우에 한하여 접종할 것을<br>권장합니다. 현재 사용하고 있는 백신들의 방어항체 양성률은 1회 접종 14일 후에 60%가량, 1개월 후에는 95% 이상이며, 2차 백신 접종 후에는 거의<br>100%에 달합니다. 따라서 접종 후의 항체검사는 필요하지 않습니다. 단, A형간염의 유행지역으로 여행하는 사람의 경우 백신접종을 일찍 서두를 것을<br>권장합니다.</p>\n<p id='61' data-category='paragraph' style='font-size:22px'>참고문헌</p>\n<p id='62' data-category='paragraph' style='font-size:16px'>1. 질병관리본부 (2020). 감염병포털. https://dportal.kdca.go.kr/pot/index.do</p>\n<p id='63' data-category='paragraph' style='font-size:18px'>본 공공저작물은 공공누리 \"출처표시+상업적이용금지+변경금지\" 조건에 따라 이용할 수 있<br>습니다.</p>\n<figure id='64'><img style='font-size:14px' alt=\" 목록\" data-coord=\"top-left:(1637,668); bottom-right:(1727,704)\" /></figure>\n<p id='65' data-category='paragraph' style='font-size:16px'>개인정보처리방침 개인정보이용안내 저작권정책 및 웹접근성</p>\n<p id='66' data-category='paragraph' style='font-size:14px'>[ 28159 ] 충청북도 청주시 흥덕구 오송읍 오송생명2로 187 오송보건의료행정타운 내 질병관리청<br>문의사항: 02-2030-6602 (평일 9:00-17:00, 12:00-13:00 제외) / 관리자 이메일 : nhis@korea.kr<br>COPYRIGHT @ 2024 질병관리청. ALL RIGHT RESERVED</p>\n<br><p id='67' data-category='paragraph' style='font-size:16px'>해외기관  유관기관  정부기관</p>\n<br><p id='68' data-category='paragraph' style='font-size:16px'></p>\n<p id='69' data-category='paragraph' style='font-size:16px'>※ 본 페이지에서 제공하는 내용은 참고사항일 뿐 게시물에 대한 법적책임은 없음을 밝혀드립니다. 자세한 내용은 전문가와 상담하시기 바랍니다.</p>\n<br><figure id='70'><img alt=\"\" data-coord=\"top-left:(2151,939); bottom-right:(2257,1019)\" /></figure>",
    "markdown": "",
    "text": ""
  },
  "elements": [
    {
      "category": "heading1",
      "content": {
        "html": "<h1 id='0' style='font-size:22px'>A형간염</h1>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0327,
          "y": 0.015
        },
        {
          "x": 0.0872,
          "y": 0.015
        },
        {
          "x": 0.0872,
          "y": 0.0319
        },
        {
          "x": 0.0327,
          "y": 0.0319
        }
      ],
      "id": 0,
      "page": 1
    },
    {
      "category": "heading1",
      "content": {
        "html": "<h1 id='1' style='font-size:20px'>요약문</h1>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0357,
          "y": 0.0453
        },
        {
          "x": 0.0692,
          "y": 0.0453
        },
        {
          "x": 0.0692,
          "y": 0.0602
        },
        {
          "x": 0.0357,
          "y": 0.0602
        }
      ],
      "id": 1,
      "page": 1
    },
    {
      "base64_encoding": "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",
      "category": "figure",
      "content": {
        "html": "<br><figure id='2'><img style='font-size:16px' alt=\"건강담기 수정 문의\" data-coord=\"top-left:(931,0); bottom-right:(1216,34)\" /></figure>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.4755,
          "y": 0.0001
        },
        {
          "x": 0.6212,
          "y": 0.0001
        },
        {
          "x": 0.6212,
          "y": 0.0163
        },
        {
          "x": 0.4755,
          "y": 0.0163
        }
      ],
      "id": 2,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='3' data-category='paragraph' style='font-size:14px'>■ 등록일자 : 2020-03-09 ■ 업데이트: 2025-02-20 ■ 조회 : 19027 정보신청 126</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0371,
          "y": 0.0708
        },
        {
          "x": 0.3711,
          "y": 0.0708
        },
        {
          "x": 0.3711,
          "y": 0.0854
        },
        {
          "x": 0.0371,
          "y": 0.0854
        }
      ],
      "id": 3,
      "page": 1
    },
    {
      "category": "heading1",
      "content": {
        "html": "<h1 id='4' style='font-size:22px'>개요</h1>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0339,
          "y": 0.1002
        },
        {
          "x": 0.0598,
          "y": 0.1002
        },
        {
          "x": 0.0598,
          "y": 0.1148
        },
        {
          "x": 0.0339,
          "y": 0.1148
        }
      ],
      "id": 4,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='5' data-category='paragraph' style='font-size:18px'>A형간염 바이러스 감염에 의한 급성 간염 질환으로, 제2급 법정감염병에 해당합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0335,
          "y": 0.1224
        },
        {
          "x": 0.3443,
          "y": 0.1224
        },
        {
          "x": 0.3443,
          "y": 0.1351
        },
        {
          "x": 0.0335,
          "y": 0.1351
        }
      ],
      "id": 5,
      "page": 1
    },
    {
      "category": "heading1",
      "content": {
        "html": "<h1 id='6' style='font-size:20px'>개요-신고 대상 및 방법</h1>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0331,
          "y": 0.1537
        },
        {
          "x": 0.1567,
          "y": 0.1537
        },
        {
          "x": 0.1567,
          "y": 0.168
        },
        {
          "x": 0.0331,
          "y": 0.168
        }
      ],
      "id": 6,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='7' data-category='paragraph' style='font-size:18px'>신고범위 : 환자, 의사환자, 병원체보유자</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0332,
          "y": 0.1756
        },
        {
          "x": 0.1926,
          "y": 0.1756
        },
        {
          "x": 0.1926,
          "y": 0.1881
        },
        {
          "x": 0.0332,
          "y": 0.1881
        }
      ],
      "id": 7,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='8' data-category='paragraph' style='font-size:18px'>: 신고를 위한 진단기준</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0325,
          "y": 0.2093
        },
        {
          "x": 0.12,
          "y": 0.2093
        },
        {
          "x": 0.12,
          "y": 0.2208
        },
        {
          "x": 0.0325,
          "y": 0.2208
        }
      ],
      "id": 8,
      "page": 1
    },
    {
      "category": "list",
      "content": {
        "html": "<p id='9' data-category='list' style='font-size:18px'>, 환자 : A형 간염에 부합되는 임상증상을 나타내면서, 확인 진단을 위한 검사 기준에 따라 감염병 병원체 감염이 확인된 사람</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0359,
          "y": 0.2262
        },
        {
          "x": 0.4913,
          "y": 0.2262
        },
        {
          "x": 0.4913,
          "y": 0.2384
        },
        {
          "x": 0.0359,
          "y": 0.2384
        }
      ],
      "id": 9,
      "page": 1
    },
    {
      "category": "list",
      "content": {
        "html": "<p id='10' data-category='list' style='font-size:18px'>· 의사환자 : 임상증상 및 역학적 연관성\"을 감안하여 A형간염이 의심되나 진단을 위한 검사기준에 부합하는 검사결과가 없는 사람<br>+ 역학적 연관성 : 환자의 증상발생 전 15~50일 동안 감염력이 있는\" A형간염 환자와 일상접촉 성접촉 경력이 있는 경우<br>+*환자의 증상 발생 2주전 - 증상발생 1주 후<br>· 병원체보유자 : 임상증상은 없으나 진단을 위한 검사기준에 따라 감염병병원제 감염이 확인된 사람</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0366,
          "y": 0.2457
        },
        {
          "x": 0.5085,
          "y": 0.2457
        },
        {
          "x": 0.5085,
          "y": 0.3107
        },
        {
          "x": 0.0366,
          "y": 0.3107
        }
      ],
      "id": 10,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='11' data-category='paragraph' style='font-size:16px'>· 진단을 위한 검사기준</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0341,
          "y": 0.3309
        },
        {
          "x": 0.1196,
          "y": 0.3309
        },
        {
          "x": 0.1196,
          "y": 0.3426
        },
        {
          "x": 0.0341,
          "y": 0.3426
        }
      ],
      "id": 11,
      "page": 1
    },
    {
      "category": "list",
      "content": {
        "html": "<p id='12' data-category='list' style='font-size:18px'>' 검체(혈액)에서 특이 IgM 항체 검출<br>· 검체(혈액, 대변, 직장도말)에서 특이 유전자 검출</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0345,
          "y": 0.3476
        },
        {
          "x": 0.2273,
          "y": 0.3476
        },
        {
          "x": 0.2273,
          "y": 0.3768
        },
        {
          "x": 0.0345,
          "y": 0.3768
        }
      ],
      "id": 12,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='13' data-category='paragraph' style='font-size:18px'>신고시기 : 24시간 이내 신고</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0339,
          "y": 0.3972
        },
        {
          "x": 0.1471,
          "y": 0.3972
        },
        {
          "x": 0.1471,
          "y": 0.41
        },
        {
          "x": 0.0339,
          "y": 0.41
        }
      ],
      "id": 13,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='14' data-category='paragraph' style='font-size:18px'>신고 방법 : 신고세를 작성하여 관할 보건소로 팩스 또는 웹[바로가기]의 방법으로 신고</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0332,
          "y": 0.4293
        },
        {
          "x": 0.3571,
          "y": 0.4293
        },
        {
          "x": 0.3571,
          "y": 0.4437
        },
        {
          "x": 0.0332,
          "y": 0.4437
        }
      ],
      "id": 14,
      "page": 1
    },
    {
      "category": "heading1",
      "content": {
        "html": "<h1 id='15' style='font-size:20px'>개요-원인 및 감염경로</h1>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0333,
          "y": 0.4609
        },
        {
          "x": 0.1537,
          "y": 0.4609
        },
        {
          "x": 0.1537,
          "y": 0.4759
        },
        {
          "x": 0.0333,
          "y": 0.4759
        }
      ],
      "id": 15,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='16' data-category='paragraph' style='font-size:16px'>1. 전파경로</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0342,
          "y": 0.4839
        },
        {
          "x": 0.0788,
          "y": 0.4839
        },
        {
          "x": 0.0788,
          "y": 0.496
        },
        {
          "x": 0.0342,
          "y": 0.496
        }
      ],
      "id": 16,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='17' data-category='paragraph' style='font-size:18px'>대부분의 경우 A형 간염 바이러스에 오염된 물이나 음식 등을 섭취하면서 경구를 통해 감염되나, 주사기를 통한 감염(습관성 약물 중독자), 혈액제제를 통한 감염,<br>성접촉을 통한 감염 등 비경 구 적으로도 전화될 수 있습니다. 주로 경구를 통해 감염되므로 환자를 통해 가족 또는 친척에게 전파되거나 안구말도가 높은 군대,<br>보육원 등 집단시설에서 집단 발생할 수 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0321,
          "y": 0.5002
        },
        {
          "x": 0.621,
          "y": 0.5002
        },
        {
          "x": 0.621,
          "y": 0.5366
        },
        {
          "x": 0.0321,
          "y": 0.5366
        }
      ],
      "id": 17,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='18' data-category='paragraph' style='font-size:18px'>2. 전명기간</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0321,
          "y": 0.5575
        },
        {
          "x": 0.0791,
          "y": 0.5575
        },
        {
          "x": 0.0791,
          "y": 0.5687
        },
        {
          "x": 0.0321,
          "y": 0.5687
        }
      ],
      "id": 18,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='19' data-category='paragraph' style='font-size:18px'>증상 발현 2주 젠부터 황달이 생긴 후 1주일까지이며, 증상이 발현하기 1~2주 전이 가장 감염력이 높은 시기입니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0321,
          "y": 0.5736
        },
        {
          "x": 0.4548,
          "y": 0.5736
        },
        {
          "x": 0.4548,
          "y": 0.5861
        },
        {
          "x": 0.0321,
          "y": 0.5861
        }
      ],
      "id": 19,
      "page": 1
    },
    {
      "category": "heading1",
      "content": {
        "html": "<h1 id='20' style='font-size:20px'>역학 및 통계</h1>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0332,
          "y": 0.6051
        },
        {
          "x": 0.1006,
          "y": 0.6051
        },
        {
          "x": 0.1006,
          "y": 0.6192
        },
        {
          "x": 0.0332,
          "y": 0.6192
        }
      ],
      "id": 20,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='21' data-category='paragraph' style='font-size:18px'>대부분 공중위생 상태가 나쁜 경우 잘 생기므로 위생 수준이 멀막했던 1960~70년대에는 소아기 감염으로 자연면역이 형성되어 성인 발생 반도가 매우<br>낮았습니다. 그러나 최근에는 위생수준 향상으로 소아기 감염이 거의 없어지게 되고 그보다는 성인 연령증(20~40대)에서의 발생 반도가 급격하게 증가하고<br>있습니다. 즉, 위생 상태 불량으로 인한 후진국형 유행 양상에서 선진국형 양상으로 변모된 것입니다. 질병관리본부에서는 200 1년부터 2009년도까지는<br>A형간염을 표본감시 대상 감염병으로서 유행을 모니터링하였으며, 2010년 제정된 '감염병의 예방 및 관리에 관한 법률' 에서 A형간염을 제2급 감염병으로<br>지정함에 따라 이 질환을 전수 감시하기 시작하였습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0323,
          "y": 0.626
        },
        {
          "x": 0.6221,
          "y": 0.626
        },
        {
          "x": 0.6221,
          "y": 0.6855
        },
        {
          "x": 0.0323,
          "y": 0.6855
        }
      ],
      "id": 21,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='22' data-category='paragraph' style='font-size:18px'>국내에서는 20~40대가 전체 환자의 80% 이상을 차지하며, 2011년 5,521명 발생 이후 매년 1,000여 명 수준으로 신고되었습니다. 그러다가 2016~2017년<br>4,500명 내외로 급증한 이후 2018년 2,437명으로 감소했다가 2019년 대규모 유행으로 17,000명 이상의 확진자가 발생하였습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0326,
          "y": 0.6908
        },
        {
          "x": 0.6225,
          "y": 0.6908
        },
        {
          "x": 0.6225,
          "y": 0.7149
        },
        {
          "x": 0.0326,
          "y": 0.7149
        }
      ],
      "id": 22,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='23' data-category='paragraph' style='font-size:14px'>. 표 시험 간염의 국내현황></p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.2878,
          "y": 0.7409
        },
        {
          "x": 0.3657,
          "y": 0.7409
        },
        {
          "x": 0.3657,
          "y": 0.752
        },
        {
          "x": 0.2878,
          "y": 0.752
        }
      ],
      "id": 23,
      "page": 1
    },
    {
      "category": "table",
      "content": {
        "html": "<br><table id='24' style='font-size:14px'><tr><td>연도</td><td>2010년</td><td>2011년</td><td>2012년</td><td>2013년</td><td>2014년</td><td>2015년</td><td>2016년</td><td>2017 년</td><td>2018년</td><td>20:18 년</td></tr><tr><td>신고 건수 (전수림시체계)</td><td></td><td>5,521 견</td><td>1,197건</td><td>867 건</td><td>1,307,건</td><td>1,804 간</td><td>4,679 건</td><td>4,419 건</td><td>2,437 건</td><td>17,598 권</td></tr></table>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0352,
          "y": 0.7553
        },
        {
          "x": 0.6225,
          "y": 0.7553
        },
        {
          "x": 0.6225,
          "y": 0.8053
        },
        {
          "x": 0.0352,
          "y": 0.8053
        }
      ],
      "id": 24,
      "page": 1
    },
    {
      "category": "list",
      "content": {
        "html": "<p id='25' data-category='list' style='font-size:14px'>·A형 간염 : 2000년 지정감염병/표본검사) - 2010년(제1군 감염병/전수강시) - 2020년(제2급 김명병/전수감씨)<br>- 출처 : 질병관리본부 (2020), 감염 법포될 http://www kdca.go krtmpt/bla/npp/itt/imple/smplefstScatskstatem. do?lcdCd=N800086/cdg/pCd=02</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0321,
          "y": 0.8092
        },
        {
          "x": 0.4606,
          "y": 0.8092
        },
        {
          "x": 0.4606,
          "y": 0.8278
        },
        {
          "x": 0.0321,
          "y": 0.8278
        }
      ],
      "id": 25,
      "page": 1
    },
    {
      "category": "heading1",
      "content": {
        "html": "<h1 id='26' style='font-size:22px'>증상</h1>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0336,
          "y": 0.8508
        },
        {
          "x": 0.0598,
          "y": 0.8508
        },
        {
          "x": 0.0598,
          "y": 0.8656
        },
        {
          "x": 0.0336,
          "y": 0.8656
        }
      ],
      "id": 26,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='27' data-category='paragraph' style='font-size:18px'>1. 장복기</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0335,
          "y": 0.8736
        },
        {
          "x": 0.0695,
          "y": 0.8736
        },
        {
          "x": 0.0695,
          "y": 0.8843
        },
        {
          "x": 0.0335,
          "y": 0.8843
        }
      ],
      "id": 27,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='28' data-category='paragraph' style='font-size:18px'>감염 후 15~50일로 평균 28~30일의 잠복기 후 임상증상이 나타납니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0338,
          "y": 0.8897
        },
        {
          "x": 0.2974,
          "y": 0.8897
        },
        {
          "x": 0.2974,
          "y": 0.9014
        },
        {
          "x": 0.0338,
          "y": 0.9014
        }
      ],
      "id": 28,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='29' data-category='paragraph' style='font-size:18px'>2. 임상증상</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0326,
          "y": 0.9231
        },
        {
          "x": 0.0788,
          "y": 0.9231
        },
        {
          "x": 0.0788,
          "y": 0.9343
        },
        {
          "x": 0.0326,
          "y": 0.9343
        }
      ],
      "id": 29,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='30' data-category='paragraph' style='font-size:18px'>발열, 식욕감퇴, 구역, 구토, 쇠약감, 복통, 설사 등 다른 바이러스 간염과 유사합니다. 일주일 이내에 특징적인 황달 증상이 발생하는데, 각막 및 피부 황달, 콜라색<br>소변, 전신 가려움증 등에 이에 속합니다. 소아의 경우 6세 미만에서 대부분 무증상(약 70%)이며 약 10%에서만 황달 증상이 발생하나, 연령이 높아질수록<br>증상에 심한 경우가 않습니다. 치명적인 전격성 간염으로 발전하는 경우는 0.1~0.3%로 알려져 있으나, 50세 이상에서는 1.8%로 높아집니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0327,
          "y": 0.9382
        },
        {
          "x": 0.6229,
          "y": 0.9382
        },
        {
          "x": 0.6229,
          "y": 0.9746
        },
        {
          "x": 0.0327,
          "y": 0.9746
        }
      ],
      "id": 30,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='31' data-category='paragraph' style='font-size:18px'>수주~수개월 후 회복되며 만성 간염은 없으나, 감염 환자의 약 15%는 A형간염이 1년까지 지속 또는 개발할 수 있다고 알려져 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0322,
          "y": 0.9793
        },
        {
          "x": 0.5292,
          "y": 0.9793
        },
        {
          "x": 0.5292,
          "y": 0.9923
        },
        {
          "x": 0.0322,
          "y": 0.9923
        }
      ],
      "id": 31,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='32' data-category='paragraph' style='font-size:20px'>진단 및 검사</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3687,
          "y": 0.0027
        },
        {
          "x": 0.414,
          "y": 0.0027
        },
        {
          "x": 0.414,
          "y": 0.0167
        },
        {
          "x": 0.3687,
          "y": 0.0167
        }
      ],
      "id": 32,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='33' data-category='paragraph' style='font-size:14px'>항A형 간염 바이러스 면역글로불린 M(IgM anti-HAV) 항체 검사 혹은 역전사중합효소연쇄반응법(RT-PCR) 등으로 A형간염 바이러스의 표적 유전자를 확인하는<br>방법을 통해 확진합니다. 면역글로불린 M 항체는 증상이 나타나기 5-10일 전부터 나타나 감염 후 6개월까지도 지속될 수 있습니다. 면역글로불린 G(IgG anti-<br>HAV) 항체는 간염의 회복기에서 양성으로 나타나며, 평생 지속됩니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3673,
          "y": 0.0249
        },
        {
          "x": 0.7522,
          "y": 0.0249
        },
        {
          "x": 0.7522,
          "y": 0.0569
        },
        {
          "x": 0.3673,
          "y": 0.0569
        }
      ],
      "id": 33,
      "page": 2
    },
    {
      "base64_encoding": "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",
      "category": "figure",
      "content": {
        "html": "<figure id='34'><img alt=\"\" data-coord=\"top-left:(1416,190); bottom-right:(1951,481)\" /></figure>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.4721,
          "y": 0.0813
        },
        {
          "x": 0.6505,
          "y": 0.0813
        },
        {
          "x": 0.6505,
          "y": 0.2056
        },
        {
          "x": 0.4721,
          "y": 0.2056
        }
      ],
      "id": 34,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='35' data-category='paragraph' style='font-size:14px'>[경과]</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3691,
          "y": 0.232
        },
        {
          "x": 0.3851,
          "y": 0.232
        },
        {
          "x": 0.3851,
          "y": 0.2422
        },
        {
          "x": 0.3691,
          "y": 0.2422
        }
      ],
      "id": 35,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='36' data-category='paragraph' style='font-size:14px'>황달이 생기기 전 혈청 간 효소가 증가하며, 알라닌아미노전이효소(ALT, GPT) 수치가 아스파라진산 아미노전이효소(AST, GOT) 수치보다 훨씬 증가하게 됩니다.<br>황달을 진단하는 혈청 빌리루빈 수치는 대개 10 이상 증가하며, 기타 염증 인자 수치도 증가하게 됩니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3663,
          "y": 0.2428
        },
        {
          "x": 0.7534,
          "y": 0.2428
        },
        {
          "x": 0.7534,
          "y": 0.2695
        },
        {
          "x": 0.3663,
          "y": 0.2695
        }
      ],
      "id": 36,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='37' data-category='paragraph' style='font-size:20px'>예방 및 예방접종</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3686,
          "y": 0.286
        },
        {
          "x": 0.4283,
          "y": 0.286
        },
        {
          "x": 0.4283,
          "y": 0.2992
        },
        {
          "x": 0.3686,
          "y": 0.2992
        }
      ],
      "id": 37,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='38' data-category='paragraph' style='font-size:14px'>• 공중 보건위생 : 손 씻기, 상하수도 정비, 식수원 오염방지, 식품 및 식품 취급자 위생관리 등이 중요합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3701,
          "y": 0.3066
        },
        {
          "x": 0.6279,
          "y": 0.3066
        },
        {
          "x": 0.6279,
          "y": 0.3182
        },
        {
          "x": 0.3701,
          "y": 0.3182
        }
      ],
      "id": 38,
      "page": 2
    },
    {
      "category": "list",
      "content": {
        "html": "<p id='39' data-category='list' style='font-size:14px'>• A형간염 백신 접종<br>1회 접종 후 6~12개월이 지나면 1회 더 접종하며, 면역은 20년 이상 지속됩니다. 다음의 상황에서 우선적으로 접종합니다.<br>- 12~23개월의 모든 소아<br>- A형간염에 대한 면역력이 없는 고위험군* 소아청소년이나 성인<br>* A형간염 고위험군<br>- 유행지역 여행자 및 장기 체류자<br>- 남성 동성애자<br>- 불법 약물 남용자<br>- 직업적으로 A형 간염에 노출될 위험이 있는 자<br>- 만성 간질환 환자<br>- 혈액응고 질환자<br>- A형간염 환자와 접촉하는 자</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3685,
          "y": 0.3367
        },
        {
          "x": 0.668,
          "y": 0.3367
        },
        {
          "x": 0.668,
          "y": 0.5155
        },
        {
          "x": 0.3685,
          "y": 0.5155
        }
      ],
      "id": 39,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='40' data-category='paragraph' style='font-size:20px'>치료</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3685,
          "y": 0.5324
        },
        {
          "x": 0.3864,
          "y": 0.5324
        },
        {
          "x": 0.3864,
          "y": 0.5464
        },
        {
          "x": 0.3685,
          "y": 0.5464
        }
      ],
      "id": 40,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='41' data-category='paragraph' style='font-size:14px'>아직까지 A형 간염 바이러스를 치료하는 약은 개발되지 않았습니다. 일반적으로 증상을 완화시키기 위한 대증요법이 주된 치료이며, 고단백 식이요법과 간에<br>휴식을 주는 것이 치료에 도움이 됩니다. 심한 증상을 동반하는 경우에는 입원 치료를 하여 증상을 완화시켜 주기도 합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3685,
          "y": 0.554
        },
        {
          "x": 0.7503,
          "y": 0.554
        },
        {
          "x": 0.7503,
          "y": 0.5757
        },
        {
          "x": 0.3685,
          "y": 0.5757
        }
      ],
      "id": 41,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='42' data-category='paragraph' style='font-size:20px'>합병증</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3688,
          "y": 0.5933
        },
        {
          "x": 0.3937,
          "y": 0.5933
        },
        {
          "x": 0.3937,
          "y": 0.6062
        },
        {
          "x": 0.3688,
          "y": 0.6062
        }
      ],
      "id": 42,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='43' data-category='paragraph' style='font-size:14px'>A형 간염의 합병증으로 길랭-바레 증후군, 급성 신부전, 담낭염, 췌장염, 혈관염, 관절염 등이 생길 수 있습니다. 소수에서 재발성 간염, 자가 면역성 간염, 담즙<br>정체성 간염 등의 비전형적인 임상 증상이 나타날 수 있습니다. 전격성 간염은 가장 중증의 합병증으로 치명률이 80%에 이른다고 알려져 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3673,
          "y": 0.6131
        },
        {
          "x": 0.7498,
          "y": 0.6131
        },
        {
          "x": 0.7498,
          "y": 0.635
        },
        {
          "x": 0.3673,
          "y": 0.635
        }
      ],
      "id": 43,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='44' data-category='paragraph' style='font-size:20px'>대상별 맞춤 정보</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3685,
          "y": 0.6529
        },
        {
          "x": 0.4289,
          "y": 0.6529
        },
        {
          "x": 0.4289,
          "y": 0.6661
        },
        {
          "x": 0.3685,
          "y": 0.6661
        }
      ],
      "id": 44,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='45' data-category='paragraph' style='font-size:14px'>1. 환자 발견</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3686,
          "y": 0.6731
        },
        {
          "x": 0.3995,
          "y": 0.6731
        },
        {
          "x": 0.3995,
          "y": 0.683
        },
        {
          "x": 0.3686,
          "y": 0.683
        }
      ],
      "id": 45,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='46' data-category='paragraph' style='font-size:14px'>다른 바이러스성 간염에서와 같이 A형 간염도 발열, 식욕부진, 구역, 전신 쇠약감 등의 비특이적인 증상으로 시작하는데, 일반적인 치료에도 불구하고 증상<br>호전이 없고, 진행하여 황달 등의 간염의 특이 증상들이 발생할 때는 의사의 진료를 받아 보는 것이 좋습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3672,
          "y": 0.688
        },
        {
          "x": 0.7521,
          "y": 0.688
        },
        {
          "x": 0.7521,
          "y": 0.71
        },
        {
          "x": 0.3672,
          "y": 0.71
        }
      ],
      "id": 46,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='47' data-category='paragraph' style='font-size:14px'>2. 환자 관리</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3688,
          "y": 0.7285
        },
        {
          "x": 0.4002,
          "y": 0.7285
        },
        {
          "x": 0.4002,
          "y": 0.7398
        },
        {
          "x": 0.3688,
          "y": 0.7398
        }
      ],
      "id": 47,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='48' data-category='paragraph' style='font-size:14px'>입원 치료가 원칙이며, 증상 및 감염력이 소실될 때까지 실시합니다. A형 간염은 대부분 환자의 대변으로 배설되어 전파되므로 장내 배설물을 격리하고, 발병 후<br>2주간 또는 황달 발생 1주간은 전염력이 높으므로 이 기간은 특별히 주의해서 손 씻기 등 개인위생을 철저히 하는 것이 좋습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.367,
          "y": 0.7441
        },
        {
          "x": 0.7518,
          "y": 0.7441
        },
        {
          "x": 0.7518,
          "y": 0.7664
        },
        {
          "x": 0.367,
          "y": 0.7664
        }
      ],
      "id": 48,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='49' data-category='paragraph' style='font-size:14px'>3. 접촉자 관리</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3683,
          "y": 0.7847
        },
        {
          "x": 0.4057,
          "y": 0.7847
        },
        {
          "x": 0.4057,
          "y": 0.7943
        },
        {
          "x": 0.3683,
          "y": 0.7943
        }
      ],
      "id": 49,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='50' data-category='paragraph' style='font-size:14px'>환자 접촉자는 노출 후 50일간 발병 여부를 감시합니다. 또한 노출 후 2주 이내에 예방접종 또는 면역글로불린 투여를 통해 예방할 수 있는데, 노출 후 예방접종은<br>빨리 접종할수록 효과가 높으므로 되도록 빠른 시간 내에 접종하도록 합니다. 12개월 미만의 영아이거나 백신 금기사항이 있는 경우에 해당하는 사람은<br>면역글로불린을 투여하며, 그 외 면역저하자나 만성간질환자, 혹은 고령자의 경우에는 담당 의료진이 위험평가 후 필요성에 따라 투여를 고려합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3675,
          "y": 0.7991
        },
        {
          "x": 0.7533,
          "y": 0.7991
        },
        {
          "x": 0.7533,
          "y": 0.8338
        },
        {
          "x": 0.3675,
          "y": 0.8338
        }
      ],
      "id": 50,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='51' data-category='paragraph' style='font-size:20px'>자주하는 질문</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3688,
          "y": 0.8503
        },
        {
          "x": 0.4187,
          "y": 0.8503
        },
        {
          "x": 0.4187,
          "y": 0.8635
        },
        {
          "x": 0.3688,
          "y": 0.8635
        }
      ],
      "id": 51,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='52' data-category='paragraph' style='font-size:16px'>Q. A형간염 백신을 꼭 접종해야 하나요?</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3685,
          "y": 0.8761
        },
        {
          "x": 0.4777,
          "y": 0.8761
        },
        {
          "x": 0.4777,
          "y": 0.888
        },
        {
          "x": 0.3685,
          "y": 0.888
        }
      ],
      "id": 52,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='53' data-category='paragraph' style='font-size:14px'>A.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3692,
          "y": 0.8948
        },
        {
          "x": 0.3758,
          "y": 0.8948
        },
        {
          "x": 0.3758,
          "y": 0.9033
        },
        {
          "x": 0.3692,
          "y": 0.9033
        }
      ],
      "id": 53,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='54' data-category='paragraph' style='font-size:16px'>Q. A형간염 백신의 2차 접종을 실수로 3개월 만에 했습니다. 이후 접종을 어떻게 해야 할까요?</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3683,
          "y": 0.9684
        },
        {
          "x": 0.6221,
          "y": 0.9684
        },
        {
          "x": 0.6221,
          "y": 0.9795
        },
        {
          "x": 0.3683,
          "y": 0.9795
        }
      ],
      "id": 54,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='55' data-category='paragraph' style='font-size:14px'>A형간염 고위험군의 경우 접종을 해야 합니다.A형간염에 대한 면역력이 없는 성인 중 A형간염의 유행지역(미국, 캐나다, 서유럽, 북유럽, 일본, 뉴질랜드,<br>호주 이외의 국가)으로의 여행자나 장기 체류자, 남자 동성애자, 불법약물 남용자, 직업적으로 노출될 위험이 있는 자(실험실 종사자, 의료인, 군인, 요식업<br>종사자 등), 만성 간 질환자, 혈액응고 질환자, A형간염 환자와 접촉하는 자, A형간염에 대한 면역을 얻기 원하는 자에게 접종을 합니다. 이들 중 만 40세<br>미만에서는 항체검사 없이 접종하고, 40세 이상에서는 항체검사를 실시하고 항체가 없는 경우에만 접종합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3734,
          "y": 0.9091
        },
        {
          "x": 0.7488,
          "y": 0.9091
        },
        {
          "x": 0.7488,
          "y": 0.9528
        },
        {
          "x": 0.3734,
          "y": 0.9528
        }
      ],
      "id": 55,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='56' data-category='paragraph' style='font-size:14px'>A.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3692,
          "y": 0.9863
        },
        {
          "x": 0.3758,
          "y": 0.9863
        },
        {
          "x": 0.3758,
          "y": 0.9948
        },
        {
          "x": 0.3692,
          "y": 0.9948
        }
      ],
      "id": 56,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='57' data-category='paragraph' style='font-size:16px'>1차와 2차와의 최소 접종간격이 6개월이므로 확실한 면역을 얻기 위해서는 잘못 접종 받은 날로부터 최소 6개월 후 재접종 해야 합니다.A형간염 백신의 2차<br>접종시기는 백신의 종류에 따라 차이가 있으나 모두 1차 접종 6개월 이후로 6~12개월에 실시합니다. 이것의 의미는 1차와 2차와의 최소 접종간격이<br>6개월이라는 것입니다. 따라서 확실한 면역을 얻기 위한 올바른 재접종 시기는 2차 접종의 6~12개월 후입니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3729,
          "y": 0.0211
        },
        {
          "x": 0.7476,
          "y": 0.0211
        },
        {
          "x": 0.7476,
          "y": 0.0554
        },
        {
          "x": 0.3729,
          "y": 0.0554
        }
      ],
      "id": 57,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='58' data-category='paragraph' style='font-size:20px'>Q. A형간염 백신의 접종 전이나 후에 항체검사를 해야 하나요?</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3682,
          "y": 0.0646
        },
        {
          "x": 0.5369,
          "y": 0.0646
        },
        {
          "x": 0.5369,
          "y": 0.0771
        },
        {
          "x": 0.3682,
          "y": 0.0771
        }
      ],
      "id": 58,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='59' data-category='paragraph' style='font-size:16px'>A.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3692,
          "y": 0.0833
        },
        {
          "x": 0.3758,
          "y": 0.0833
        },
        {
          "x": 0.3758,
          "y": 0.0918
        },
        {
          "x": 0.3692,
          "y": 0.0918
        }
      ],
      "id": 59,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='60' data-category='paragraph' style='font-size:16px'>A형간염의 방어항체 양성률은 2차 접종 후에는 거의 100%에 달하므로 접종 후의 항체검사는 필요하지 않습니다.백신 접종 전의 항체검사의 실시여부는<br>백신 가격과 검사 비용 간의 경제적 요인 및 인구의 항체 보유율에 의해 결정됩니다. 만약 백신 접종력이나 A형간염의 이환력이 없어 백신을 접종하기로<br>결정하였다면 만 40세 미만에서는 검사 없이 백신을 접종하고, 40세 이상이라면 백신 투여 전에 검사를 시행하여 항체가 없는 경우에 한하여 접종할 것을<br>권장합니다. 현재 사용하고 있는 백신들의 방어항체 양성률은 1회 접종 14일 후에 60%가량, 1개월 후에는 95% 이상이며, 2차 백신 접종 후에는 거의<br>100%에 달합니다. 따라서 접종 후의 항체검사는 필요하지 않습니다. 단, A형간염의 유행지역으로 여행하는 사람의 경우 백신접종을 일찍 서두를 것을<br>권장합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3732,
          "y": 0.0993
        },
        {
          "x": 0.747,
          "y": 0.0993
        },
        {
          "x": 0.747,
          "y": 0.163
        },
        {
          "x": 0.3732,
          "y": 0.163
        }
      ],
      "id": 60,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='61' data-category='paragraph' style='font-size:22px'>참고문헌</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3684,
          "y": 0.1855
        },
        {
          "x": 0.4014,
          "y": 0.1855
        },
        {
          "x": 0.4014,
          "y": 0.1974
        },
        {
          "x": 0.3684,
          "y": 0.1974
        }
      ],
      "id": 61,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='62' data-category='paragraph' style='font-size:16px'>1. 질병관리본부 (2020). 감염병포털. https://dportal.kdca.go.kr/pot/index.do</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3696,
          "y": 0.2055
        },
        {
          "x": 0.5643,
          "y": 0.2055
        },
        {
          "x": 0.5643,
          "y": 0.2179
        },
        {
          "x": 0.3696,
          "y": 0.2179
        }
      ],
      "id": 62,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='63' data-category='paragraph' style='font-size:18px'>본 공공저작물은 공공누리 \"출처표시+상업적이용금지+변경금지\" 조건에 따라 이용할 수 있<br>습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.5059,
          "y": 0.2413
        },
        {
          "x": 0.7416,
          "y": 0.2413
        },
        {
          "x": 0.7416,
          "y": 0.2652
        },
        {
          "x": 0.5059,
          "y": 0.2652
        }
      ],
      "id": 63,
      "page": 3
    },
    {
      "base64_encoding": "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",
      "category": "figure",
      "content": {
        "html": "<figure id='64'><img style='font-size:14px' alt=\" 목록\" data-coord=\"top-left:(1637,668); bottom-right:(1727,704)\" /></figure>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.5458,
          "y": 0.2853
        },
        {
          "x": 0.576,
          "y": 0.2853
        },
        {
          "x": 0.576,
          "y": 0.3005
        },
        {
          "x": 0.5458,
          "y": 0.3005
        }
      ],
      "id": 64,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='65' data-category='paragraph' style='font-size:16px'>개인정보처리방침 개인정보이용안내 저작권정책 및 웹접근성</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.263,
          "y": 0.3384
        },
        {
          "x": 0.4357,
          "y": 0.3384
        },
        {
          "x": 0.4357,
          "y": 0.3517
        },
        {
          "x": 0.263,
          "y": 0.3517
        }
      ],
      "id": 65,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='66' data-category='paragraph' style='font-size:14px'>[ 28159 ] 충청북도 청주시 흥덕구 오송읍 오송생명2로 187 오송보건의료행정타운 내 질병관리청<br>문의사항: 02-2030-6602 (평일 9:00-17:00, 12:00-13:00 제외) / 관리자 이메일 : nhis@korea.kr<br>COPYRIGHT @ 2024 질병관리청. ALL RIGHT RESERVED</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.2629,
          "y": 0.37
        },
        {
          "x": 0.5081,
          "y": 0.37
        },
        {
          "x": 0.5081,
          "y": 0.4027
        },
        {
          "x": 0.2629,
          "y": 0.4027
        }
      ],
      "id": 66,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='67' data-category='paragraph' style='font-size:16px'>해외기관  유관기관  정부기관</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.5528,
          "y": 0.3719
        },
        {
          "x": 0.7237,
          "y": 0.3719
        },
        {
          "x": 0.7237,
          "y": 0.3864
        },
        {
          "x": 0.5528,
          "y": 0.3864
        }
      ],
      "id": 67,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='68' data-category='paragraph' style='font-size:16px'></p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.7342,
          "y": 0.3745
        },
        {
          "x": 0.7408,
          "y": 0.3745
        },
        {
          "x": 0.7408,
          "y": 0.383
        },
        {
          "x": 0.7342,
          "y": 0.383
        }
      ],
      "id": 68,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='69' data-category='paragraph' style='font-size:16px'>※ 본 페이지에서 제공하는 내용은 참고사항일 뿐 게시물에 대한 법적책임은 없음을 밝혀드립니다. 자세한 내용은 전문가와 상담하시기 바랍니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.2666,
          "y": 0.4194
        },
        {
          "x": 0.6166,
          "y": 0.4194
        },
        {
          "x": 0.6166,
          "y": 0.4324
        },
        {
          "x": 0.2666,
          "y": 0.4324
        }
      ],
      "id": 69,
      "page": 3
    },
    {
      "base64_encoding": "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",
      "category": "figure",
      "content": {
        "html": "<br><figure id='70'><img alt=\"\" data-coord=\"top-left:(2151,939); bottom-right:(2257,1019)\" /></figure>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.7173,
          "y": 0.4009
        },
        {
          "x": 0.7526,
          "y": 0.4009
        },
        {
          "x": 0.7526,
          "y": 0.4348
        },
        {
          "x": 0.7173,
          "y": 0.4348
        }
      ],
      "id": 70,
      "page": 3
    }
  ],
  "merged_elements": [],
  "model": "document-parse-250116",
  "ocr": true,
  "usage": {
    "pages": 3
  }
}